PubRank

Wiete Westerhof

Author PubWeight™ 13.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Noninvasive techniques for the evaluation of skin color. J Am Acad Dermatol 2006 1.43
2 Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 2003 1.41
3 UVB 311 nm tolerance of vitiligo skin increases with skin photo type. Acta Derm Venereol 2005 1.40
4 Increased epidermal functioning wild-type p53 expression in vitiligo. Exp Dermatol 2003 0.99
5 Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study. J Am Acad Dermatol 2006 0.97
6 Progressive macular hypomelanosis: an overview. Am J Clin Dermatol 2007 0.94
7 Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res 2004 0.88
8 A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity. Chem Res Toxicol 2009 0.86
9 Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res 2011 0.83
10 Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation. J Pathol 2002 0.81
11 Progressive macular hypomelanosis is associated with a putative Propionibacterium species. J Invest Dermatol 2009 0.79
12 Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study. Photodermatol Photoimmunol Photomed 2008 0.79
13 Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%/tretinoin 0.01% solution and sunscreen in solar lentigines. Cutis 2004 0.75
14 Comment on the letter by Chung et al. about progressive macular hypomelanosis. J Eur Acad Dermatol Venereol 2008 0.75
15 The effect of H₁ and H₂ receptor antagonists on melanogenesis. Indian J Dermatol Venereol Leprol 2011 0.75